Associate Director, Clinical Genomics Development Geisinger Medical Laboratories
This workshop features initial experiences with the Oncomine Comprehensive Assay Plus on the Genexus System for next-day comprehensive genomic profiling (CGP) results. This complete, end-to-end CGP solution detects a broad range of genomic alterations across 517 genes, including single-nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs), and fusions. Additionally, the assay detects genomic signatures such as homologous recombination deficiency (HRD), tumor mutational burden (TMB), and microsatellite instability (MSI). Hear how labs can benefit from this easy, automated, and complete solution.
